More than 1 in 8 participants treated with retatrutide became completely free of knee pain by the end of the trial
In practice, GLP-1 medications can: Reduce hunger and food intake Improve insulin sensitivity Lower blood sugar levels Support fat loss (especially visceral fat) These effects are especially relevant during menopause, when weight gain and metabolic changes often become more common, despite no major changes in diet or exercise habits
StubbsBKoyanagiAVeroneseNVancampfortDSolmiMGaughranFet al
The SURPASS-CVOT and retatrutide Phase 3 cardiovascular trials will generate the datasets that establish whether the dual- and triple-agonist compounds replicate the CV-outcome signal semaglutide produced, exceed it, or diverge from it
Research highlights that GHK-Cu+ could: Transport essential copper directly to cells in a bioavailable form Contribute to skin rejuvenation and protective effect Potentially improve elasticity and restore the foundational elements of skin Lead to sustained collagen production and skin hydration
doi: 10.1186/s12864-021-07951-1 203 Skerrett-ByrneDATriggNABromfieldEGDunMDBernsteinIRAndersonALet al
